Press releases
- Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
- Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes
- Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
- Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
- Insulet to Present at the Jefferies Global Healthcare Conference
- Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
- Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
More ▼
Key statistics
As of last trade, Insulet Corp (GOV:MUN) traded at 176.90, 48.16% above the 52 week low of 119.40 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 176.90 |
---|---|
High | 176.90 |
Low | 176.90 |
Bid | 177.15 |
Offer | 181.75 |
Previous close | 176.85 |
Average volume | 0.43 |
---|---|
Shares outstanding | 70.04m |
Free float | 69.80m |
P/E (TTM) | 61.53 |
Market cap | 13.84bn USD |
EPS (TTM) | 3.21 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 07:00 BST.
More ▼